{"id":3624,"company":{"country":"GB","currency":"GBP","exchange":"LONDON STOCK EXCHANGE","ipo":"1972-05-22","marketCap":59331.2,"name":"GSK plc","phone":"442080475000","outstanding":4076.15,"symbol":"GSK","website":"https://www.gsk.com/","industry":"Pharmaceuticals"},"price":45.1325,"year":2024,"month":5,"day":23,"weekday":"Thursday","title":"Potential Risks of Investing in GSK Plc Stock","date":"2024-05-23","url":"/posts/2024/05/23/GSK","content":[{"section":"Regulatory Challenges","text":"GSK operates in a highly regulated industry, and the company may face challenges related to regulatory changes, such as new drug approval processes, patent expirations, and pricing regulations. Compliance with evolving regulations and potential legal issues can impact GSK's financial performance."},{"section":"Intense Competition","text":"The pharmaceutical industry is highly competitive, with numerous companies vying for market share. GSK competes against both large multinational companies and smaller specialized firms. Intense competition can affect GSK's ability to maintain and grow its market position, potentially impacting its revenue and profits."},{"section":"R\u0026D Success and Pipeline","text":"GSK's future success largely depends on its research and development (R\u0026D) efforts. The company invests a significant amount in discovering new drugs and therapies. However, the R\u0026D process is inherently risky, with no guarantee of successful outcomes. Failures in R\u0026D can lead to significant financial losses and hinder the introduction of new products to the market."},{"section":"Patent Expirations","text":"Like most pharmaceutical companies, GSK faces the risk of patent expirations for its key drugs. When patents expire, generic competitors can enter the market, resulting in a decline in revenue for GSK. The company's ability to effectively manage the impact of patent expirations by introducing new patented drugs or utilizing other strategies is crucial for sustaining its profitability."},{"section":"Litigation and Product Liability","text":"GSK operates in an industry where product liability claims and litigation risks exist. Adverse effects or liability claims related to the use of its products can result in financial losses, damage to reputation, and legal expenses. Vigilance in maintaining high safety standards and effective risk management practices is essential for mitigating these risks."},{"section":"Global Economic Conditions","text":"GSK's operations span multiple countries and are subject to global economic conditions. Economic downturns, currency fluctuations, political instability, and trade disputes can impact the company's sales, profitability, and ability to access new markets. Monitoring and adapting to macroeconomic factors is crucial for managing these risks."},{"section":"Healthcare Policy and Pricing Pressures","text":"Changes in healthcare policies, government regulations, and pricing pressures can influence GSK's revenue and profitability. Government interventions, such as price controls or reimbursement changes, can impact drug prices and market access. GSK needs to navigate these policy dynamics effectively to optimize its financial performance."},{"section":"Health and Safety Risks","text":"As a pharmaceutical company, GSK faces inherent health and safety risks associated with drug manufacturing, clinical trials, and supply chain management. Ensuring high safety standards, product quality control, and minimizing operational risks related to health and safety are crucial for GSK's reputation and financial stability."}],"tags":["LongSignals","Long","Pharmaceuticals"],"news":[{"category":"company","date":1716378300,"headline":"GSK Pharma call volume above normal and directionally bullish","id":127843906,"image":"","symbol":"GSK","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3507539032"},{"category":"company","date":1716376756,"headline":"GSK Breathes New Life Into Asthma Treatment With Depemokimab","id":127839483,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1658122564/image_1658122564.jpg?io=getty-c-w1536","symbol":"GSK","publisher":"SeekingAlpha","summary":"GSK plc's innovative depemokimab therapy for severe asthma offers long-acting benefits, reduced exacerbations and solid earnings. Click here for my GSK update.","url":"https://seekingalpha.com/article/4695015-gsk-breathes-new-life-into-asthma-treatment-with-depemokimab"},{"category":"company","date":1716372480,"headline":"Australia reports first human case of bird flu","id":127839809,"image":"","symbol":"GSK","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3507411884"},{"category":"company","date":1716317318,"headline":"GSK Concealed Risk Associated With Discontinued Heart Burn Drug Zantac, Whistleblower Lawsuit Claims","id":127820606,"image":"https://media.zenfs.com/en/Benzinga/d2d698a69ab54305c5eb7cca62830f71","symbol":"GSK","publisher":"Yahoo","summary":"GSK Plc (NYSE:GSK) has been reportedly sued by an independent Connecticut laboratory, Valisure, accusing the pharmaceutical giant of defrauding the U.S. government and taxpayers by concealing cancer risks associated with Zantac, once a blockbuster heartburn drug. Related: Pfizer Agrees To Settle Over 10,000 Lawsuits About Cancer Risks Associated With Discontinued Heartburn Drug Zantac. In a whistleblower complaint filed on Monday, Valisure claimed GSK violated the federal False Claims Act by hid","url":"https://finance.yahoo.com/news/gsk-concealed-risk-associated-discontinued-184838528.html"},{"category":"company","date":1716306198,"headline":"European Stocks Decline as Investors Eye Nvidia, Rates Outlook","id":127822075,"image":"https://media.zenfs.com/en/bloomberg_markets_842/8287477c35faac10b787d54577f233fc","symbol":"GSK","publisher":"Yahoo","summary":"(Bloomberg) -- European stocks dropped as investors turned their focus to this week’s earnings from artificial intelligence-bellwether Nvidia Corp. while monitoring for fresh clues on the outlook for interest rates.Most Read from BloombergOne Dead After Singapore Air Flight Hit By Severe TurbulenceASML, TSMC Can Disable Chip Machines If China Invades TaiwanHims Debuts $199 Weight-Loss Shots at 85% Discount to Wegovy‘It Felt Like We Had Crashed,’ a Singapore Air Passenger RecallsTesla Shareholder","url":"https://finance.yahoo.com/news/european-stocks-decline-investors-eye-154318244.html"},{"category":"company","date":1716301892,"headline":"GSK's Experimental Asthma Drug Reduces Severe Attacks, Phase 3 Trial Data Shows","id":127815669,"image":"https://media.zenfs.com/en/Benzinga/690cf1d7ba46bbeda5aec50078e9df27","symbol":"GSK","publisher":"Yahoo","summary":"Tuesday, GSK plc (NYSE:GSK) released headline results from the phase III clinical trials SWIFT-1 and SWIFT-2, which assessed the efficacy and safety of depemokimab versus placebo in adults and adolescents with severe asthma with type 2 inflammation characterized by blood eosinophil count. Earlier this year, GSK acquired Aiolos Bio Inc., a privately held asthma drug maker, for $1 billion. Both SWIFT-1 and SWIFT-2 met their primary endpoints of a reduction in the annualized rate of clinically sign","url":"https://finance.yahoo.com/news/gsks-experimental-asthma-drug-reduces-143132058.html"},{"category":"company","date":1716292200,"headline":"GSK’s Potential Blockbuster Asthma Drug Shows Promise in Latest Trial","id":127815670,"image":"https://s.yimg.com/ny/api/res/1.2/09Rt.m1hJQaK2GszPqh0Wg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/wsj.com/56f594baa3b1c1cbdfd26dc64db4799b","symbol":"GSK","publisher":"Yahoo","summary":"GSK said two late-stage trials of an asthma drug that could have peak sales of almost $4 billion met their goals.","url":"https://finance.yahoo.com/m/450425eb-9d21-3972-9692-6bf374e65b68/gsk%E2%80%99s-potential-blockbuster.html"},{"category":"company","date":1716286200,"headline":"Potential blockbuster asthma drug met goals in trials, GSK says","id":127818842,"image":"","symbol":"GSK","publisher":"MarketWatch","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3505697798"},{"category":"company","date":1716277620,"headline":"Morning Brew: Macy's Raises Revenue Guidance Amid Strong Q1 Results, Lam Research Announces $10B","id":127815160,"image":"","symbol":"GSK","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3505523944"},{"category":"company","date":1716277020,"headline":"GSK succeeds in late-stage trials for asthma candidate","id":127818844,"image":"","symbol":"GSK","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3505512402"},{"category":"company","date":1716275511,"headline":"GSK’s New Vaccine Kept the Boss in Her Job — and an Activist at Bay","id":127815671,"image":"https://s.yimg.com/ny/api/res/1.2/MNJAdxR8MswD4POi2JDQsA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/bloomberg_markets_842/e5c1b7a236d3693e91c76201fb36d252","symbol":"GSK","publisher":"Yahoo","summary":"(Bloomberg) -- When Elliott Investment Management came calling for the ouster of Emma Walmsley, the chief executive officer of GSK Plc found her remedy in a product almost 60 years in the making.Most Read from BloombergOne Dead After Singapore Air Flight Hit By Severe TurbulenceASML, TSMC Can Disable Chip Machines If China Invades TaiwanHims Debuts $199 Weight-Loss Shots at 85% Discount to WegovyJamie Dimon Says Succession at JPMorgan Is ‘Well on the Way’Tesla Shareholder Group Slams Elon Musk’s","url":"https://finance.yahoo.com/news/gsks-vaccine-kept-boss-her-040022238.html"},{"category":"company","date":1716268680,"headline":"GSK announces SWIFT-1, SWIFT-2 trials on depemokimab met primary endpoints","id":127818846,"image":"","symbol":"GSK","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3505378915"},{"category":"company","date":1716263340,"headline":"GSK's depemokimab asthma treatment meets endpoints in latest trials","id":127818847,"image":"","symbol":"GSK","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=azdxvtxsbk"},{"category":"company","date":1716258360,"headline":"GSK says late-stage trials of potential blockbuster asthma drug met their goals","id":127818848,"image":"","symbol":"GSK","publisher":"MarketWatch","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3505245601"},{"category":"company","date":1716256320,"headline":"GSK’s Depemokimab Shows Promise in Asthma Trials","id":127818849,"image":"","symbol":"GSK","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3505221422"},{"category":"company","date":1716236841,"headline":"GSK whistleblower claims drugmaker cheated US government over Zantac cancer risk","id":127806542,"image":"https://media.zenfs.com/en/reuters-finance.com/8ab183106255182de39460f195e6449c","symbol":"GSK","publisher":"Yahoo","summary":"(Reuters) -GSK has been sued by an independent Connecticut laboratory that accused the drugmaker of defrauding the U.S. government and taxpayers by concealing cancer risks in Zantac, once a blockbuster heartburn drug.  In a whistleblower complaint filed on Monday, Valisure said GSK violated the federal False Claims Act by hiding the risks for nearly four decades while Medicare, Medicaid and other health programs covered billions of dollars of prescriptions.  The New Haven-based lab said its testing in 2019 revealed that Zantac, also known as ranitidine, could form a cancer-causing carcinogen known as NMDA and was therefore \"unfit for human consumption.\"","url":"https://finance.yahoo.com/news/gsk-faces-whistleblower-lawsuit-over-202721783.html"},{"category":"company","date":1716209820,"headline":"GSK facing whistleblower lawsuit from lab related to Zantac, Bloomberg says","id":127806115,"image":"","symbol":"GSK","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3504267762"},{"category":"company","date":1716207180,"headline":"GSK says FDA approves Benlysta Autoinjector for children with SLE","id":127806116,"image":"","symbol":"GSK","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3504214181"},{"category":"company","date":1716203460,"headline":"IN BRIEF: GSK executive buys GBP20,026 worth shares","id":127806117,"image":"","symbol":"GSK","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=diee34te8t"},{"category":"company","date":1716198480,"headline":"GSK Executives Engage in Stock Transactions","id":127806118,"image":"","symbol":"GSK","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3504046356"},{"category":"company","date":1716170100,"headline":"GSK faces another Zantac whistleblower lawsuit","id":127806119,"image":"","symbol":"GSK","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3504338822"},{"category":"company","date":1716084420,"headline":"SA Roundtable: Are Eli Lilly and Novo Nordisk overvalued?","id":127790807,"image":"","symbol":"GSK","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3503224853"},{"category":"company","date":1715997240,"headline":"Novo Nordisk, J\u0026J lead R\u0026D rankings in big pharma: report","id":127778728,"image":"","symbol":"GSK","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3502273184"},{"category":"company","date":1715945940,"headline":"GSK to Divest Final Shares in Haleon","id":127758813,"image":"","symbol":"GSK","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3500710013"},{"category":"company","date":1715941069,"headline":"GlaxoSmithKline Pharma India posts higher Q4 adjusted profit on strong sales","id":127764542,"image":"https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png","symbol":"GSK","publisher":"Yahoo","summary":"Drugmaker GlaxoSmithKline Pharma India reported a 49% rise in fourth-quarter adjusted profit on Friday, as strong demand for its generic medicines offset the impact of the government's ongoing price curbs on its key drugs.  Revenue from operations rose 18% to 9.30 billion rupees, led by a 12% growth in its generic medicines portfolio which the company attributed to key focus brands Augmentin, Ceftum and Calpol.  Earnings at drugmakers like GlaxoSmithKline Pharma and Abbott India have been pressured as prices of some of their key drugs were capped under the Indian government's essential medicines list (NLEM) since September 2022.","url":"https://sg.finance.yahoo.com/news/glaxosmithkline-pharma-india-posts-higher-101749601.html"},{"category":"company","date":1715939340,"headline":"GSK Completely Exits Sensodyne Toothpaste Maker Haleon In $1.6B Sale","id":127756792,"image":"","symbol":"GSK","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3500577901"},{"category":"company","date":1715936504,"headline":"FTSE 100 Live 17 May: LandSec shares fall on results, GSK in £1.25bn final Haleon stake sale","id":127756267,"image":"https://static.standard.co.uk/2023/12/04/13/03/ftse100live.JPG.jpg?width=1200\u0026auto=webp\u0026quality=75","symbol":"GSK","publisher":"Yahoo","summary":"GSK and Land Securities are in the FTSE 100 spotlight after the drugs giant sold its final Haleon shares and the property firm posted results.  The sale of GSK’s remaining 4% stake raised £1.25 billion, having held 13% following its 2022 demerger of the Panadol and Sensodyne business.  Land Securities revealed a smaller full-year loss of £341 million amid “robust” rental growth across its estate.","url":"https://www.standard.co.uk/business/ftse-100-live-17-may-land-securities-results-dow-jones-stocks-shares-b1158338.html"},{"category":"company","date":1715935004,"headline":"Trending tickers: Tesla, Reddit, Walmart and GSK","id":127756268,"image":"https://s.yimg.com/ny/api/res/1.2/bQIO66VcR_twE37iQXkyjQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MjU-/https://s.yimg.com/os/creatr-uploaded-images/2024-04/41bcb540-fd19-11ee-bebe-d5ba1a5ca57c","symbol":"GSK","publisher":"Yahoo","summary":"The latest investor updates on stocks that are trending on Friday.","url":"https://uk.finance.yahoo.com/news/tesla-reddit-walmart-gsk-trending-tickers-083644191.html"},{"category":"company","date":1715929659,"headline":"GSK to Sell Remaining $1.6 Billion Stake in Haleon","id":127756270,"image":"https://s.yimg.com/ny/api/res/1.2/kA9_7onYy4o1cd9.AO8XsQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03OTM-/https://media.zenfs.com/en/bloomberg_markets_842/c85f49f145783d69d254b60a4ee13595","symbol":"GSK","publisher":"Yahoo","summary":"(Bloomberg) -- GSK Plc will sell its remaining stake in Haleon Plc for £1.25 billion ($1.6 billion), completing the drugmaker’s separation from the consumer health company.Most Read from BloombergChina Attempts to End Property Crisis With Broad Rescue PackageWith a BlackRock CEO, $9 Trillion Vanguard Braces for TurbulenceUS Inflation Data Was Accidentally Released 30 Minutes EarlyPutin and Xi Vow to Step Up Fight to Counter US ‘Containment’Jamie Dimon Sees ‘Lot of Inflationary Forces in Front of","url":"https://finance.yahoo.com/news/gsk-sell-remaining-1-6-063414281.html"},{"category":"company","date":1715929320,"headline":"GSK sale of remaining Haleon stake nets more than $1.5B","id":127757875,"image":"","symbol":"GSK","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3500396389"},{"category":"company","date":1715928720,"headline":"LONDON MARKET MIDDAY: FTSE 100 slides; Eurozone inflation steady","id":127757876,"image":"","symbol":"GSK","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=e6m9pxtplz"},{"category":"company","date":1715925540,"headline":"GSK Finalizes Exit from Haleon with £1.2B Sale","id":127758817,"image":"","symbol":"GSK","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3500336619"},{"category":"company","date":1715918580,"headline":"TOP NEWS: GSK sells remaining Haleon stake for GBP1.25 billion","id":127756795,"image":"","symbol":"GSK","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=2t23z127f4"},{"category":"company","date":1715918160,"headline":"LONDON MARKET OPEN: FTSE 100 lacklustre as Wall Street rally ends","id":127757878,"image":"","symbol":"GSK","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=shauvaowmn"},{"category":"company","date":1715913720,"headline":"LONDON BRIEFING: Land Securities ups dividend; GSK sells Haleon stake","id":127757873,"image":"","symbol":"GSK","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=wqfifhpe1f"},{"category":"company","date":1715909820,"headline":"GSK Finalizes Total Exit from Haleon Shares","id":127758823,"image":"","symbol":"GSK","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3500132796"},{"category":"company","date":1715861580,"headline":"TOP NEWS: GSK to sell remaining holding in spin-off Haleon","id":127746303,"image":"","symbol":"GSK","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=hk5xloeybp"},{"category":"company","date":1715860440,"headline":"LONDON MARKET CLOSE: Europe struggles but record highs in New York","id":127737891,"image":"","symbol":"GSK","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=wb61rqgudo"},{"category":"company","date":1715859300,"headline":"GSK to sell entire Haleon stake","id":127746306,"image":"","symbol":"GSK","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3498922839"},{"category":"company","date":1715856600,"headline":"GSK to Sell Entire Stake in Haleon","id":127746308,"image":"","symbol":"GSK","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3498858304"},{"category":"company","date":1715856420,"headline":"GSK announces intention to sell about 385M shares in Haleon","id":127738119,"image":"","symbol":"GSK","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3498854474"},{"category":"company","date":1715846100,"headline":"Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game","id":127738176,"image":"","symbol":"GSK","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3498619925"},{"category":"company","date":1715836680,"headline":"Patent Peril: 3 Stocks at Risk From the FTC’s Drug Crusade","id":127738595,"image":"","symbol":"GSK","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3498457707"},{"category":"company","date":1715835060,"headline":"Pfizer agrees to pay up to $250M to settle Zantac cancer lawsuits - report","id":127738597,"image":"","symbol":"GSK","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3498434368"},{"category":"company","date":1715771760,"headline":"GSK goes ex dividend tomorrow","id":127722599,"image":"","symbol":"GSK","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3496989139"},{"category":"company","date":1715770980,"headline":"UK dividends calendar - next 7 days","id":127708741,"image":"","symbol":"GSK","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=jo002v6bxv"},{"category":"company","date":1715770980,"headline":"UK dividends calendar","id":127708725,"image":"","symbol":"GSK","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=9c62q4s45h"},{"category":"company","date":1715770974,"headline":"GSK PLC's Dividend Analysis","id":127707563,"image":"https://s.yimg.com/ny/api/res/1.2/ROlU2.xH_pcKm1NL7XwuHQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03NjU-/https://media.zenfs.com/en/us.finance.gurufocus/ec611effc963a4504fe45ef66a4563da","symbol":"GSK","publisher":"Yahoo","summary":"GSK PLC (NYSE:GSK) recently announced a dividend of $0.38 per share, payable on July 11, 2024, with the ex-dividend date set for May 16, 2024.  As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates.  Utilizing the data from GuruFocus, let's delve into GSK PLC's dividend performance and assess its sustainability.","url":"https://finance.yahoo.com/news/gsk-plcs-dividend-analysis-110254664.html"},{"category":"company","date":1715768400,"headline":"Aristotle Capital International Equity ADR Q1 2024 Commentary","id":127707684,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/96502248/image_96502248.jpg?io=getty-c-w1536","symbol":"GSK","publisher":"SeekingAlpha","summary":"For the first quarter of 2024, Aristotle Capitalâs International Equity ADR Composite posted a total return of 3.89% gross of fees, underperforming the MSCI EAFE Index.","url":"https://seekingalpha.com/article/4693451-aristotle-capital-international-equity-adr-q1-2024-commentary"},{"category":"company","date":1715738520,"headline":"Organon \u0026 Co Spearheads Kahn Brothers' Strategic Portfolio Enhancements in Q1 2024","id":127714755,"image":"","symbol":"GSK","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3497239136"},{"category":"company","date":1715686200,"headline":"GSK Executives Invest in Company’s Future","id":127684348,"image":"","symbol":"GSK","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3495142383"},{"category":"company","date":1715678820,"headline":"GSK, Abu Dhabi partner to establi regional vaccine distribution hub","id":127684352,"image":"","symbol":"GSK","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3494972825"},{"category":"company","date":1715667300,"headline":"Double-Up Delights: 7 Stocks Poised to Soar 100% by 2025","id":127684353,"image":"","symbol":"GSK","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3494745042"},{"category":"company","date":1715663460,"headline":"LONDON BROKER RATINGS: DB and Berenberg raise Diploma price target","id":127681796,"image":"","symbol":"GSK","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=x7yseh7v3i"},{"category":"company","date":1715599800,"headline":"GSK Reports Latest Securities Allotment Status","id":127667224,"image":"","symbol":"GSK","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3493196523"},{"category":"company","date":1715585460,"headline":"GLOBAL BROKER RATINGS: BAE Systems, Henkel and Mondi cut to 'neutral'","id":127658079,"image":"","symbol":"GSK","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=uq8f25y5dr"},{"category":"company","date":1715585220,"headline":"GlaxoSmithKline (GSK) Gets a Buy from Jefferies","id":127667228,"image":"","symbol":"GSK","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3492856524"},{"category":"company","date":1715577780,"headline":"Amazon Pours ~$1.3B Investment Into French Operations: Report","id":127660779,"image":"","symbol":"GSK","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3492729531"},{"category":"company","date":1715575260,"headline":"LONDON BROKER RATINGS: BAE Systems and Mondi cut to 'neutral'","id":127658692,"image":"","symbol":"GSK","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=t5gwzmk454"},{"category":"company","date":1715569380,"headline":"Amazon to invest $1.3 bln in France, create 3,000 jobs - report","id":127663308,"image":"","symbol":"GSK","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3492621979"},{"category":"company","date":1715416425,"headline":"GSK plc (LON:GSK) Stock Goes Ex-Dividend In Just Four Days","id":127632508,"image":"https://media.zenfs.com/en/simply_wall_st__316/a99782b24065c2e10ff5cc21f6727f48","symbol":"GSK","publisher":"Yahoo","summary":"Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see GSK plc...","url":"https://finance.yahoo.com/news/gsk-plc-lon-gsk-stock-083345051.html"},{"category":"company","date":1715248832,"headline":"Moderna's New RSV Vaccine Undercuts the Promise of mRNA","id":127567966,"image":"https://s.yimg.com/ny/api/res/1.2/vUCP42NmqJLgGoPOoFQYSA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03MzA-/https://media.zenfs.com/en/bloomberg_markets_842/9ae8c4d294c6373508ad05a0ae644ec7","symbol":"GSK","publisher":"Yahoo","summary":"(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion biotech giant and a public health hero. Its second vaccine, meant to prevent a common respiratory virus, is calling into question the premise on which the company has staked its entire business. Most Read from BloombergMicrosoft’s Xbox Is Planning More Cuts After Studio ClosingsAmericans Are Racking Up ‘Phantom Debt’ That Wall Street Can’t TrackStormy Daniels Will Return to Court in Test of Trump’s","url":"https://finance.yahoo.com/news/moderna-mrna-dreams-meet-reality-100032918.html"},{"category":"company","date":1715248140,"headline":"June 28th Options Now Available For GSK","id":127608822,"image":"","symbol":"GSK","publisher":"Stock Options Channel","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3486625453"},{"category":"company","date":1715241000,"headline":"Top 5 Health Care Stocks That Could Sink Your Portfolio In Q2","id":127576902,"image":"","symbol":"GSK","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3486407888"},{"category":"company","date":1715239020,"headline":"Wave Life Sciences appoints Erik Ingelsson as CSO","id":127590081,"image":"","symbol":"GSK","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3486355805"},{"category":"company","date":1715233047,"headline":"GSK (LON:GSK) Is Paying Out A Dividend Of £0.15","id":127561747,"image":"https://media.zenfs.com/en/simply_wall_st__316/a99782b24065c2e10ff5cc21f6727f48","symbol":"GSK","publisher":"Yahoo","summary":"GSK plc's ( LON:GSK ) investors are due to receive a payment of £0.15 per share on 11th of July. The dividend yield...","url":"https://finance.yahoo.com/news/gsk-lon-gsk-paying-dividend-053727741.html"}]}